search
Back to results

Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease (ETHEPAT)

Primary Purpose

Stroke, Myocardial Infarction

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Optimized conventional therapy alone
Optimized conventional therapy with therapeutic education
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Stroke focused on measuring Cardiovascular, therapeutic education

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients hospitalized for a cardiovascular event (myocardial infarction); Neurovascular attack (TIA or stroke)
  • Patients whose age is between 18 and 75 years
  • Patients who signed the informed consent after information about the study

Exclusion Criteria:

  • Subject participating or having participated in another study that alters conventional management of hospitalized patients for stroke, transient ischemic attack or myocardial infarction
  • Significant cognitive troubles making transmission of questionnaire impossible, or speech or understanding disorders (including non francophone patients)

Sites / Locations

  • CEPTA (Centre d'Exploration, de Prévention et de Traitement de l'Athérosclérose), Hôpital Cardiologique du Haut-Lévêque

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control group

Intervention group

Arm Description

Outcomes

Primary Outcome Measures

Difference measure of the risk factors score between baseline and 1 year of follow-up
The sum of the different risk factors score is calculated at the baseline and the year 1. Then the difference between both is calculated.

Secondary Outcome Measures

Assessment of the improvement of at least one point of the risk score between baseline and 1 year of follow-up
Each risk factor score is compared individually at the baseline and the year 1 to assess if at least one risk factor score improved from the Baseline (success or failure).
Measure of the Framingham score giving a risk prediction of recurrent cardiovascular event

Full Information

First Posted
June 28, 2016
Last Updated
February 8, 2022
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT02819791
Brief Title
Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease
Acronym
ETHEPAT
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
June 5, 2014 (Actual)
Primary Completion Date
April 14, 2017 (Actual)
Study Completion Date
April 14, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The Exploration Center for Prevention and Treatment of Atherosclerosis (CEPTA, Bordeaux Hospital University) showed that following myocardial infarct (MI) or ischemic stroke (TIA or stroke), the global management (medical and educational) of patients led to very long-term satisfactory results in terms of reduction of cardiovascular (CV) risk and morbidity and mortality. However, the specific effect of therapeutic education beyond the conventional treatment has never been an adequate assessment. The following at 1 year of this study will show the evolution of chronic long-term CV disease in patients who received therapeutic education, and to explain the mechanisms. The challenge of this project is to demonstrate for the first time the superiority of therapeutic education and conventional care and propose a modeling program for national diffusion. Patients who experienced a CV event (MI, stroke) will be randomized into 2 groups of 165 patients each: 1) receiving conventional treatment alone; 2) receiving conventional treatment + CEPTA program. The study was built for a 1-year follow-up period, to demonstrate the impact of therapeutic education on evolution of risk factors, physical, psychological and social health of patients. The main benefit of this study for the patient is the implementation of an optimized treatment and long-term monitoring by a cardiology referral center.
Detailed Description
Chronic cardiovascular diseases are the second cause of death in France, and represent a major public health issue. Recurrences are numerous, due to inadequate control of cardiovascular risk factors, despite significant drug prescription. Therapeutic education can help to improve the health of patients, physical and psychical. The Exploration Center for Prevention and Treatment of Atherosclerosis (CEPTA, Bordeaux Hospital University) demonstrated that following myocardial infarction or stroke, the comprehensive care (medical and educational) of patients CEPTA led to results very satisfactory in terms of reduction of cardiovascular risk and morbidity and mortality. However, the specific effect of therapeutic education beyond the conventional treatment has never been a proper assessment. This study is a single-center prospective, randomized, controlled. The main objective is to find and explain the impact of the "therapeutic education program" in addition to optimized conventional therapy in post-MI or stroke patients, compared to an optimized conventional therapy alone . Patients will be randomized during hospitalization for their acute phase into two groups of 165 patients each. The first group receiving conventional therapy alone and the 2nd group receiving conventional treatment + the therapeutic education program. All patients benefit from traditional monitoring as provided for this type of patients, followed up for 3 months and 1 year. In the first days after the acute event, patients benefit from the most appropriate treatment and receive guidance for their change in lifestyle, diet and smoking cessation. Optimal treatment will be prescribed to the output depending on cardiovascular status and risk factors. Three months after cardiovascular events, patients will benefit from their assessment of atherosclerosis and its consequences on myocardial or neurological functions. Each patient will receive an assessment of risk factors (smoking, dietary habits and physical activity). Personalized advice will be issued. One participants group will receive the "conventional treatment + therapeutic education program (CEPTA program)". The objectives of the therapeutic education associate: Of learning objectives and acquisition of knowledge and self-care skills making the patient more autonomous and facilitating its adherence. the objectives of acquiring coping skills (self-confidence, stress management, setting projects) to improve their quality of life. the development objectives respects the relevant criteria of quality, realism and principle of educational progress. The challenge of this project is to demonstrate for the first time the superiority of a conventional treatment + therapeutic education in this population, and to propose a model program for national broadcast.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Myocardial Infarction
Keywords
Cardiovascular, therapeutic education

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
202 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
Active Comparator
Arm Title
Intervention group
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Optimized conventional therapy alone
Intervention Description
Patients will benefit from a traditional follow-up as provided for this type of patients at 3 months and 1 year
Intervention Type
Behavioral
Intervention Name(s)
Optimized conventional therapy with therapeutic education
Intervention Description
The objectives of this therapeutic education program involve: learning objectives and acquisition of knowledge and self-care skills making the patient more autonomous and facilitating its adherence. the objectives of acquiring coping skills ( self-confidence , stress management , setting projects ) to improve their quality of life . the development objectives respects the relevant criteria of quality , realism and principle of educational progress.
Primary Outcome Measure Information:
Title
Difference measure of the risk factors score between baseline and 1 year of follow-up
Description
The sum of the different risk factors score is calculated at the baseline and the year 1. Then the difference between both is calculated.
Time Frame
Baseline to year 1
Secondary Outcome Measure Information:
Title
Assessment of the improvement of at least one point of the risk score between baseline and 1 year of follow-up
Description
Each risk factor score is compared individually at the baseline and the year 1 to assess if at least one risk factor score improved from the Baseline (success or failure).
Time Frame
Baseline to year 1
Title
Measure of the Framingham score giving a risk prediction of recurrent cardiovascular event
Time Frame
Day 1, month 3, year 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients hospitalized for a cardiovascular event (myocardial infarction); Neurovascular attack (TIA or stroke) Patients whose age is between 18 and 75 years Patients who signed the informed consent after information about the study Exclusion Criteria: Subject participating or having participated in another study that alters conventional management of hospitalized patients for stroke, transient ischemic attack or myocardial infarction Significant cognitive troubles making transmission of questionnaire impossible, or speech or understanding disorders (including non francophone patients)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Louis-Rachid SALMI, Pr
Organizational Affiliation
Unité de Soutien Méthodologique à la Recherche clinique et épidémiologique du CHU de Bordeaux
Official's Role
Study Chair
Facility Information:
Facility Name
CEPTA (Centre d'Exploration, de Prévention et de Traitement de l'Athérosclérose), Hôpital Cardiologique du Haut-Lévêque
City
Pessac
ZIP/Postal Code
33604
Country
France

12. IPD Sharing Statement

Learn more about this trial

Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease

We'll reach out to this number within 24 hrs